2
Announcements
Trials
Browse
Landscape
Status
Recruiting
1
Completed
1
Sponsor Class
OTHER
1
INDUSTRY
1
Study Type
Observational
2
Sponsor
Cancer Type
Gastrointestinal
7
Thoracic
2
Genitourinary
2
Tumor-Agnostic
1
Breast
1
Conditions
Lung Neoplasms
1
Carcinoma, Non-Small-Cell Lung
1
Interventions
Carboplatin
1167
Cisplatin
889
Pemetrexed
845
pembrolizumab
622
Paclitaxel
608
Docetaxel
539
Gemcitabine
428
Radiotherapy
390
Erlotinib Hydrochloride
381
Nivolumab
344
Bevacizumab
337
Etoposide
296
durvalumab
264
Drug Therapy
260
osimertinib
236
atezolizumab
224
Radiosurgery
194
Gefitinib
186
Vinorelbine
149
Magnetic Resonance Spectroscopy
131
Ipilimumab
129
130-nm albumin-bound paclitaxel
124
Cetuximab
113
Blood Specimen Collection
106
anlotinib
105
tislelizumab
103
Topotecan
103
Specimen Handling
102
Surgical Procedures, Operative
101
Cyclophosphamide
101
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
2 trials
Recent
Start date
Enrollment
Defecation
×
Thoracic
×
Clear all
NCT04804137
2024-01-17
RICEPS
University Hospital, Tours
Completed
24 enrolled
NCT05736029
2023-02-21
PROPHETIC
OncoHost Ltd.
Recruiting
350 enrolled